Alembic Pharmaceuticals and Amlan International, the animal health business of Oil-Dri Corporation of America, have entered into a strategic commercial agreement to introduce poultry health solutions in India.
This collaboration will expand access to advanced feed additives that improve gut health, nutrient absorption, and feed conversion ratios (FCR), ensuring better poultry yields and supporting the industry’s growing demand for high-quality protein, they said, in a joint statement. It also establishes a framework for knowledge sharing, technical training, and sustainable growth in India’s poultry sector, it said.
Shaunak Amin, Managing Director, Alembic Pharmaceuticals, said the partnership allowed it to bring scientifically backed, practical solutions to poultry farmers across India. “With Amlan’s expertise in toxin binder and gut health and with our strong presence in the market, we’re not just introducing new products, we’re addressing key challenges in poultry farming,” he said.
Opening door for innovation
P Karunanithi, Executive Vice President (Cluster Head), Animal Health Division at Alembic Pharmaceuticals, said, “Poultry production efficiency starts with a healthy intestinal environment. By integrating Amlan’s innovative feed additive technologies into our portfolio, we are strengthening our commitment to delivering science-backed solutions that enhance poultry health and performance.”
On signing of the commercial agreement, Dr W Wade Robey, VP Agriculture and President with USA’s Amlan International, added, “This strong foundation of partnership will open the door with innovative and research based products broadly reaching India’s poultry and feed milling sector. “
Oil-Dri Corporation of America is a global company involved with sorbent mineral technology and over 80 years of expertise in mineral science, the note said. It selectively mines and processes its unique minerals for both consumer and business markets, it added.